Akiram Therapeutics
PrivateLast Round
Grant
Nov 24, 2023
Est. Valuation
$12.31M
Total Funding Raised
$570,000
Company Overview
Akiram Therapeutics is a biotechnology company that develops innovative and targeted molecular radiotherapy for patients with incurable cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akiram Therapeutics Comparables
Compare Akiram Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreTT ApS | 90% | |
| Precirix | 86% | |
| Ariceum Therapeutics | 82% | |
Akiram Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 24, 2023 | ||||
| VC Round | Jan 12, 2023 |
Key People
Founding team and executive leadership
Akiram Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phase2Phase Biopharma | VC Round |
| Sciety | VC Round |
| 3T Invest | VC Round |
| Erling-Persson Foundation | Grant |
| Linc AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 4, 2025
Attending EANM Congress 2025 in Barcelona from October 4-8.
- Apr 3, 2025
Partnered with PreTT and TetraKit Technologies on targeted radiotherapy.
Akiram Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Akiram Therapeutics's valuation, stock price, and market status.